This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Yesterday’s UK 100 Leaders | Price (p) | % Chg |
Standard Chartered PLC | 635.0 | 4.9% |
Rightmove PLC | 561.2 | 1.9% |
Astrazeneca PLC | 10,220.0 | 1.8% |
Intercontinental Hotels Group PLC | 8,752.0 | 1.8% |
JD Sports Fashion PLC | 115.4 | 1.7% |
Yesterday’s UK 100 Laggards | Price (p) | % Chg |
St. James’s Place PLC | 643.0 | -3.0% |
Admiral Group PLC | 2,533.0 | -1.4% |
Schroders PLC | 397.5 | -1.3% |
Scottish Mortgage Investment Trust PLC | 787.6 | -1.2% |
Smith (Ds) PLC | 320.8 | -1.1% |
Major World Indices | Price | % Chg | 1 YEAR |
UK 100 INDEX | 7,706 | 0.3% | -2.2% |
DOW JONES INDUS. AVG | 39,132 | 0.2% | 19.2% |
DAX INDEX | 17,419 | 0.3% | 14.5% |
NIKKEI 225 | 39,234 | 0.4% | 44.8% |
S&P/ASX 200 INDEX | 7,653 | 0.1% | 4.7% |
Commodities | Units | Price | % Chg |
WTI Crude Oil (Nymex) | USD/bbl. | 76.29 | -0.26% |
Brent Crude (ICE) | USD/bbl. | 81.47 | -0.18% |
Gold Spot | USD/t oz. | 2,034 | -0.1% |
Copper (Comex) | USd/lb. | 388 | -0.5% |
The UK 100 called to open -3 points at 7,703. The UK 100 is called to open very slightly lower this morning, following a mixed trading session in Asia overnight. Japan was once again the stand out performer, as it continued to hit new highs with the NIkkei in sight of 40,000 for the first time heading towards the close. On Friday Stateside, the S&P 500 inched higher by 0.03% to close at 5,088.80. Earlier in the session, the broad market index broke above 5,100 for the first time. The Dow Jones added 62.42 points, or 0.16%, also reaching a fresh record and closing at an all-time high of 39,131.53. The Nasdaq lost 0.28% to close at 15,996.82, but had notched a fresh 52-week high earlier in the session. All three major averages registered winning weeks. The S&P advanced 1.66%, while the tech-heavy Nasdaq gained 1.4% for the week. The Dow was up 1.3% for the period.
Bunzl are to buy 80% Nisbets stake for £339m in cash. They report a FY23 pretax profit of £698.6m, up 10% YoY from £634.6m. They expect to deliver “slight revenue growth” in 2024, driven by acquisitions as they expect their group operating margin to be slightly below 2023.
GSK reports positive results in test of gepotidacin in uncomplicated urogenital gonorrhoea.
Hammerson sells Union Square, a shopping centre in Aberdeen for £111m.
Jefferies Upgrades ITM Power to Buy from Hold (6 Buys / 6 Holds / 2 Sells)
UK
Bunzl
US
Berkshire Hathaway
UK
Croda International
Smith & Nephew*
abrdn
US
Lemonade
Virgin Galactic
US New Home Sales Change
Japanese National Consumer Price Index
UK 100 companies going ex-dividend on 29th February 2024:
Barclays
Diageo
UK 250 companies going ex-dividend on 29th February 2024:
Diversified Energy Company
Plus500
Ashmore Group
JLEN Environmental Assets Group
North Atlantic Smaller Companies Inv Tst
HICL Infrastructure
Hargreaves Lansdown
LondonMetric Property
Hays
Scottish American Investment Company
Alliance Trust
Genus
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.